Fairmount Funds Management, Director: Zenas BioPharma ZBIO Buy · Filed 25/10/09

Trade details

Type: Insider buy
Amount: $6,008,161
Shares · price: 316,219 sh · $19.00 a share
Held after: 2,209,025 sh
Stock: Zenas BioPharma ZBIO
Person: Fairmount Funds ManagementDirector
Trade date: 25/10/07
Filed: 25/10/09
Days to filing: 2 days

First buy in 1 years

Since the last buy: 1.1 years
Last buy: 24/09/16
Insiders buying this week: 10 insiders
Holding change: +16.7%

Zenas BioPharma trades, last 26 weeks

What else happened in Zenas BioPharma around then

Filed or reported within 30 days of the trade day · 25/09/07~25/11/06

Fairmount Funds Management's recent trades

Fairmount Funds ManagementDirector, 10% Stockholder
Planned saleOruka Therapeutics
Planned sale
Oruka Therapeutics
ORKA
$300M
3,553,410 sh
$300M
Filed 07/01
Traded 07/01
Fairmount Funds ManagementDirector
Planned saleSpyre Therapeutics
Planned sale
Spyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
Fairmount Funds ManagementDirector
SellSpyre Therapeutics
Sell
Spyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
Fairmount Funds ManagementDirector
BuyViridian Therapeutics, Inc.\DE
Buy
Viridian Therapeutics, Inc.\DE
VRDN
$20M
1,176,470 sh
$20M
Filed 05/13
Traded 05/11
Fairmount Funds ManagementDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31